The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Amelie DarlixChristophe HirtzSimon ThezenasAleksandra MaceskiAudrey GabelleEvelyne Lopez-CrapezHélène De ForgesNelly FirminSéverine GuiuWilliam JacotSylvain Lehmann

Published in: BMC cancer (2019)

Tau is a new biomarker of interest in MBC. Its serum level could represent an independent prognostic factor in these patients (both with and without BM). It also seems to be associated with the presence of BM. A validation of these results in an independent set of MBC patients is necessary to confirm these findings.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
metastatic breast cancer
small molecule
cerebrospinal fluid
amino acid